IRCT201512252581N4已完成4 期
Comparison of the efficacy of Spironolcatone 5% and Progesterone 2% on hair density and diameter in female pattern androgenetic alopecia
Vice Chancellor for research, Tabriz University of Medical Sciences0 个研究点目标入组 36 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Female
入选标准
- •female; grade 1 or 2 androgenetic alopecia; no underlying hormonal disorders
- •Exclusion criteria: patient's decision to exit the study; underlying hormonal disorder; anemia; use of topical medications in the past week; taking oral medications in the past four weeks; have allergy to spironolactone or progesterone; pregnancy or planning to pregnancy or breastfeeding
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Comparing the effectiveness of spironolactone solution with clindamycin solution in patients with acneMild to moderate acne vulgaris.Acne vulgarisL70.0IRCT20120524009844N12Tabriz University of Medical Sciences60
招募中
2 期
Effect of spironolactone and erythromycin solution in treatment of acneAcne.AcneIRCT20181005041243N1Tehran University of Medical Sciences90
已完成
3 期
Effect of Spirnolactone in heart failureHeart failure.congestive heart failureIRCT2015010520563N1Ahwaz Jundishapur University of Medical Science100
已完成
2 期
The Effect of Spironolactone in Treatment of Essential HypertensioHypertension.Essential (primary) hypertensionIRCT201502011525N6Shiraz University of Midical Sciences40
已完成
3 期
The Efficacy of Spironolactone in Continuous Ambulatory Peritoneal Dialysis Patients with Hypokalemia: A Randomized Controlled TrialA randomized controlled trial was conducted in CAPD patients with serum potassium <3.5 mEq/L.End stage renal disease,Hypokalemia,Peritoneal dialysis,SpironolactoneTCTR20200818005one50